LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.
Frequently asked questions
What sector does LB Pharmaceuticals Inc Common Stock (LBRX) operate in?
LB Pharmaceuticals Inc Common Stock belongs to the Healthcare sector and operates in the Biotechnology industry.
What is LB Pharmaceuticals Inc Common Stock (LBRX) current stock price?
As of the latest data, LB Pharmaceuticals Inc Common Stock stock price is $39.64, with a previous close of $39.34. LB Pharmaceuticals Inc Common Stock gained $0.30 in the last trading session, representing a 0.76% increase.
What is LB Pharmaceuticals Inc Common Stock (LBRX) current market capitalization?
LB Pharmaceuticals Inc Common Stock market cap is approximately 1.28 billion.
What is LB Pharmaceuticals Inc Common Stock (LBRX) Earnings Per Share (EPS)?
The trailing EPS is -$5.06, and the forward EPS is -$5.04.
What is LB Pharmaceuticals Inc Common Stock (LBRX) EBITDA?
LB Pharmaceuticals Inc Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -53.82 million.
Does LB Pharmaceuticals Inc Common Stock (LBRX) pay dividends?
No. LB Pharmaceuticals Inc Common Stock does not pay a dividend.
When is LB Pharmaceuticals Inc Common Stock (LBRX) next earnings report?
LB Pharmaceuticals Inc Common Stock is expected to release its next earnings report on September 30, 2026.
What is LB Pharmaceuticals Inc Common Stock (LBRX) beta (volatility) score?
LB Pharmaceuticals Inc Common Stock has a beta of 0.049, indicating lower volatility than the overall market.
